Lifeward Ltd. (LS:A12BMB) Financings
Financings
| Raise | Date |
|---|---|
| Senior secured convertible notes and accompanying warrants Tranche closed: US$5.6M raised Use of proceeds: Accelerate commercialization of its restorative healthcare platform, expand its reimbursement-backed distribution model and advance its product portfolio | Jul 7, 2026 |
| Strategic investment of ordinary shares, prefunded warrants, convertible notes and warrants Announced: up to US$47M · additional warrants to acquire up to $7 million in ordinary shares of Lifeward Buyers: Oramed (up to a 49.99% equity ownership in Lifeward) Use of proceeds: Cash runway to profitability and selective investment in high-value innovation | Jan 13, 2026 |
| Public offering of ordinary shares and accompanying warrants Closed: US$2.6M raised · US$0.65 a share · Warrants at US$0.65 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Continuing commercial efforts, working capital and general corporate purposes | Jun 26, 2025 |
| Registered direct offering of ordinary shares and unregistered warrants Announced: about US$5M · US$2.75 a share · Warrants at US$2.75 for 36 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Continuing commercial efforts, working capital and general corporate purposes | Jan 7, 2025 |